Tokyo-January 29, 2009, KYORIN Co., Ltd. announces that a research paper※１on a clinical trial (PEACE Study※２) of MUCODYNE®, sold by its wholly owned subsidiary KYORIN Pharmaceutical Co., Ltd. (Headquarters: Tokyo, President: Itaru Kojo), has been selected Paper of the Year by THE LANCET.

Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008